These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

999 related articles for article (PubMed ID: 30909965)

  • 1. Isolated adrenocorticotropic hormone deficiency and thyroiditis associated with nivolumab therapy in a patient with advanced lung adenocarcinoma: a case report and review of the literature.
    Ohara N; Kobayashi M; Ohashi K; Ito R; Ikeda Y; Kawaguchi G; Yoneoka Y; Hasegawa G; Takada T
    J Med Case Rep; 2019 Mar; 13(1):88. PubMed ID: 30909965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late-onset isolated adrenocorticotropic hormone deficiency caused by nivolumab: a case report.
    Takeno A; Yamamoto M; Morita M; Tanaka S; Kanazawa I; Yamauchi M; Kaneko S; Sugimoto T
    BMC Endocr Disord; 2019 Feb; 19(1):25. PubMed ID: 30782163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case Report: A Variety of Immune-Related Adverse Events Triggered by Immune Checkpoint Inhibitors in a Subject With Malignant Melanoma: Destructive Thyroiditis, Aseptic Meningitis and Isolated ACTH Deficiency.
    Katakura Y; Kimura T; Kusano T; Tatsumi F; Iwamoto Y; Sanada J; Fushimi Y; Shimoda M; Kohara K; Nakanishi S; Kaku K; Mune T; Kaneto H
    Front Endocrinol (Lausanne); 2021; 12():722586. PubMed ID: 34712202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolated Adrenocorticotropic Hormone Deficiency Caused by Nivolumab in a Patient with Metastatic Lung Cancer.
    Takaya K; Sonoda M; Fuchigami A; Hiyoshi T
    Intern Med; 2017 Sep; 56(18):2463-2469. PubMed ID: 28824067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nivolumab-induced Hypophysitis, Secondary Adrenal Insufficiency and Destructive Thyroiditis in a Patient with Lung Adenocarcinoma.
    Mishima Y; Fukaishi T; Inase N; Isogai S
    Intern Med; 2019 Mar; 58(5):693-697. PubMed ID: 30449786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolated Adrenocorticotropin Deficiency due to Nivolumab-induced Hypophysitis in a Patient with Advanced Lung Adenocarcinoma: A Case Report and Literature Review.
    Ohara N; Ohashi K; Fujisaki T; Oda C; Ikeda Y; Yoneoka Y; Hashimoto T; Hasegawa G; Suzuki K; Takada T
    Intern Med; 2018 Feb; 57(4):527-535. PubMed ID: 29151505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary hypothyroidism and isolated ACTH deficiency induced by nivolumab therapy: Case report and review.
    Zeng MF; Chen LL; Ye HY; Gong W; Zhou LN; Li YM; Zhao XL
    Medicine (Baltimore); 2017 Nov; 96(44):e8426. PubMed ID: 29095280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated adrenocorticotropic hormone deficiency associated with nivolumab therapy.
    Narahira A; Yanagi T; Cho KY; Nakamura A; Miyoshi H; Hata H; Imafuku K; Kitamura S; Shimizu H
    J Dermatol; 2017 Apr; 44(4):e70. PubMed ID: 27608187
    [No Abstract]   [Full Text] [Related]  

  • 9. Isolated adrenocorticotropic hormone deficiency associated with sintilimab therapy in a patient with advanced lung adenocarcinoma: a case report and literature review.
    Lin SH; Zhang A; Li LZ; Zhao LC; Wu LX; Fang CT
    BMC Endocr Disord; 2022 Sep; 22(1):239. PubMed ID: 36153581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated ACTH deficiency induced by cancer immunotherapy: a systematic review.
    Iglesias P; Sánchez JC; Díez JJ
    Pituitary; 2021 Aug; 24(4):630-643. PubMed ID: 33761049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated ACTH deficiency probably induced by autoimmune-related mechanism evoked with nivolumab.
    Kitajima K; Ashida K; Wada N; Suetsugu R; Takeichi Y; Sakamoto S; Uchi H; Matsushima T; Shiratsuchi M; Ohnaka K; Furue M; Nomura M
    Jpn J Clin Oncol; 2017 May; 47(5):463-466. PubMed ID: 28334791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nivolumab-induced hypothyroidism followed by isolated ACTH deficiency.
    Martins Machado C; Almeida Santos L; Barroso A; Oliveira MJ
    BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31466960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated adrenocorticotropic hormone deficiency possibly caused by nivolumab in a metastatic melanoma patient.
    Fujimura T; Kambayashi Y; Furudate S; Kakizaki A; Hidaka T; Haga T; Hashimoto A; Morimoto R; Aiba S
    J Dermatol; 2017 Mar; 44(3):e13-e14. PubMed ID: 27440178
    [No Abstract]   [Full Text] [Related]  

  • 14. Isolated Adrenocorticotropic Hormone Deficiency in Melanoma Patients Treated with Nivolumab.
    Kitano S; Tatsuno K; Ishibe J; Shimauchi T; Fujiyama T; Ito T; Ogawa N; Tokura Y
    Acta Derm Venereol; 2018 Jul; 98(7):704-705. PubMed ID: 29405244
    [No Abstract]   [Full Text] [Related]  

  • 15. Isolated adrenocorticotropic hormone (ACTH) deficiency and Guillain-Barré syndrome occurring in a patient treated with nivolumab.
    Pierrard J; Petit B; Lejeune S; Seront E
    BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31439558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fulminant type 1 diabetes associated with Isolated ACTH deficiency induced by anti-programmed cell death 1 antibody-insight into the pathogenesis of autoimmune endocrinopathy.
    Okahata S; Sakamoto K; Mitsumatsu T; Kondo Y; Noso S; Ikegami H; Shiba T
    Endocr J; 2019 Apr; 66(4):295-300. PubMed ID: 30814440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pituitary immune-related adverse events induced by programmed cell death protein 1 inhibitors in advanced lung cancer patients: A report of 3 cases].
    Gu YC; Liu Y; Xie C; Cao BS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 54(2):369-375. PubMed ID: 35435206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nivolumab-related severe thrombocytopenia in a patient with relapsed lung adenocarcinoma: a case report and review of the literature.
    Hasegawa T; Ozaki Y; Inoue T; Watanabe Y; Fukuhara M; Yamaura T; Muto S; Okabe N; Higuchi M; Shio Y; Suzuki H
    J Med Case Rep; 2019 Oct; 13(1):316. PubMed ID: 31647029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery from secondary adrenal insufficiency in a patient with immune checkpoint inhibitor therapy induced hypophysitis.
    Thapi S; Leiter A; Galsky M; Gallagher EJ
    J Immunother Cancer; 2019 Sep; 7(1):248. PubMed ID: 31511065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple endocrinopathies, hypercalcaemia and pancreatitis following combined immune checkpoint inhibitor use- case report and review of literature.
    Newman C; Kgosidalwa O; Hakami OA; Kennedy C; Grogan L; Agha A
    BMC Endocr Disord; 2021 Feb; 21(1):33. PubMed ID: 33639911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.